Compare Medpace Holdings Inc (MEDP) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Tencent Music Entertainment Group - ADR — how do they compare? Medpace Holdings Inc trades at $528.16 (market cap $15.18B), while Tencent Music Entertainment Group - ADR trades at $8.76 (market cap $15.16B). The key difference: Medpace Holdings Inc and Tencent Music Entertainment Group - ADR are close in size by market cap, and Tencent Music Entertainment Group - ADR pays a 2.68% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | TME | |
|---|---|---|
Market Cap | $15.18B | $15.16B |
Sector | Technology | Media |
52-Week High | $620.59 | $26.36 |
52-Week Low | $393.42 | $8.16 |
Enterprise Value | $14.65B | $11.93B |
Dividend Yield | — | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% on the day, with a neutral technical signal and mixed oscillators. The stock shows strong profitability with a 17.19% net margin and 77.25% ROE, though valuations are elevated with a P/E of 33.22. Recent quarters have consistently beaten EPS estimates, but a class action lawsuit filed in June 2026 adds uncertainty. Revenue is projected to grow to $2.7B in 2026, while cash flow trends improve from negative to positive net cash flow.
The outlook is cautious due to high valuation and legal overhangs, but fundamental strength in earnings and backlog quality provides support. Analyst consensus is mixed with a $497 price target below current levels, indicating limited near-term upside. Key risks include lawsuit outcomes and competitive pressures in the CRO sector.
TME trades at $8.94, down 1.97% for the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong 2025 revenue of $32.90B and net income of $11.06B, with a net income margin of 26.48%. Recent news highlights strategic moves like the Ximalaya acquisition and a partnership with Coca-Cola for the 2026 FIFA World Cup anthem.
The outlook is mixed; analyst consensus is a 'Hold' with a $14.00 price target, implying significant upside. Key opportunities include premium membership growth and ecosystem integration, while risks involve competition, user churn, and AI-related copyright issues. Cash flow trends show a projected recovery in 2026 after a negative 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
